Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the category archives: OBN News

Personnel Changes

New appointments strengthen the Aigenpulse Leadership team

Aigenpulse Ltd., (Aigenpulse), a big data technology company which specialises in structuring, integrating and deriving meaning from large, disparate data assets in the life sciences sector, is continuing to strengthen its management team with the addition of Head of Delivery and Head of DevOps.

Read the rest of entry »

Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth

Inivata, a leader in liquid biopsy, today, 12 September, announces the strengthening of its senior leadership team with the appointment of Clive Morris, formerly Chief Medical Officer, as Chief Executive Officer, Stacy Chick as Chief Commercial Officer and Thomas Schlumpberger as VP Business Development.

Read the rest of entry »

Isansys Lifecare Hires New UK Sales Manager

Abingdon, UK: Isansys Lifecare, the market leader in new generation wireless patient monitoring technology and patient digitisation systems and services, today announced the hiring of Sam Thwaites as its new UK Sales Manager, reporting to CEO Keith Errey.

Read the rest of entry »

Caldan Therapeutics Announces Key Appointment

 Edinburgh, UK – Caldan Therapeutics, a spin-out company from the Universities of Glasgow and Southern Denmark, which specialises in developing novel therapeutics targeting free fatty acid receptors for the treatment of metabolic disease, including Type 2 Diabetes and non-alcoholic steatohepatitis (NASH), is pleased to announce the appointment of Dr Mark Payton as Chief Executive Officer (CEO).

Read the rest of entry »

Oxford BioTherapeutics Strengthens Board of Directors with Appointment of Two Biotech Veterans

Oxford, UK & San Jose, USA - Oxford BioTherapeutics (“OBT”), an international biotechnology company developing clinical stage antibody therapeutics for cancer, today announced a significant strengthening of its oncology focused Board of Directors with the appointment of Bernd Seizinger M.D., Ph.D. as Chairman and Jean-Pierre Bizzari, M.D. as a non-executive director, joining Glenn Begley, Shawn Tomasello, Tom Bradley and Christian Rohlff.

Read the rest of entry »

SRG appoints new Director for it's Clinical Division

Birmingham & London, UK - SRG has appointed Marianna Suckova as Director of Clinical, based in London. Marianna Suckova brings extensive knowledge of Drug Development along with a notable pedigree in sales activities, recruitment, change management and people leadership.

Read the rest of entry »

Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & Development

Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile infection (‘CDI’), today announces the appointment of Dr David Roblin as Chief Operating Officer (‘COO’) and President of Research and Development.

Read the rest of entry »

SRG Appoints New Director for its Clinical division

Birmingham, UK - Science, clinical and engineering recruitment company SRG has appointed Marianna Suckova as Director of Clinical, based in London.

Read the rest of entry »

e-Therapeutics Appoints Dr. Raymond Barlow as Chief Executive

Oxford, UK - e-Therapeutics plc (AIM: ETX), the drug discovery company, announces that it has appointed Dr. Raymond Barlow as Chief Executive Officer. Dr. Barlow will take up the role on or before 1 May 2017, at which point he will be appointed to the e-Therapeutics Board of Directors.

Read the rest of entry »

Charnwood Molecular Appoints New Head of Medicinal Chemistry

14 December 2016: Loughborough, UK - CRO, Charnwood Molecular Ltd, appoints Dr James Hitchin as its new Head of Medicinal Chemistry to lead its research services laboratories at BioCity, Nottingham. Dr Hitchin brings extensive experience from across multiple therapeutic areas in drug discovery to the Charnwood team.  James has previously held positions at SAFC Pharma, Pfizer Pharmaceuticals and KemFine Oy.  Most recently he was Senior Medicinal Chemist at the Cancer Research UK Manchester Institute, where he worked on various target classes, including kinases and epigenetic targets from hit identification right through to lead optimization and beyond. “I am looking forward to the challenge of leading Charnwood Molecular’s Medicinal Chemistry division”, states James. “We are experiencing significant growth in our chemistry services business, including an increase in demand for the medicinal chemistry research that we undertake at the BioCity laboratories. Charnwood&rsquo ...

Read the rest of entry »

Pages: Previous123NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.